Drug recall D-0149-2024
Product
Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66
Reason for recall
Failed Dissolution Specifications
Lots and codes
Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025
Recall details
- Recalling firm
- Siegfried Barbera, SL, Barbera Del Valles, N/A
- Quantity
- 2016
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 20, 2023
Related products
- Votrient – drug information
- NDC 0078-1077 Votrient · Pazopanib Hydrochloride 200 mg/1 · Novartis Pharmaceuticals Corporation